Literature DB >> 12897759

Evidence for human mast cell nonreleaser phenotype.

Christopher L Kepley, Neri Cohen.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12897759     DOI： 10.1067/mai.2003.1671

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  In vitro desensitization of human skin mast cells.

Authors:  Wei Zhao; Gregorio Gomez; Matthew Macey; Christopher L Kepley; Lawrence B Schwartz
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

2.  Syk deficiency in human non-releaser lung mast cells.

Authors:  Gregorio Gomez; Lawrence Schwartz; Christopher Kepley
Journal:  Clin Immunol       Date:  2007-08-10       Impact factor: 3.969

Review 3.  New approaches to allergen immunotherapy.

Authors:  Christopher L Kepley
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

4.  Uptake and distribution of fullerenes in human mast cells.

Authors:  Anthony Dellinger; Zhiguo Zhou; Sarah K Norton; Robert Lenk; Daniel Conrad; Christopher L Kepley
Journal:  Nanomedicine       Date:  2010-02-04       Impact factor: 5.307

5.  A steroid-mimicking nanomaterial that mediates inhibition of human lung mast cell responses.

Authors:  Anthony L Dellinger; Zhiguo Zhou; Christopher L Kepley
Journal:  Nanomedicine       Date:  2014-02-22       Impact factor: 5.307

Review 6.  Basophils and mast cells in chronic idiopathic urticaria.

Authors:  Becky M Vonakis; Sarbjit S Saini
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

7.  Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy.

Authors:  Jada Suber; Yugen Zhang; Ping Ye; Rishu Guo; A Wesley Burks; Michael D Kulis; Scott A Smith; Onyinye I Iweala
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.